Apollo Endosurgery to Present at HC Wainwright Conference
Back to Newsroom
Mentioned in this Article

Apollo Endosurgery to Present at HC Wainwright Conference

Friday, September 11, 2020 3:00 PM
Share this article now

AUSTIN, TX / ACCESSWIRE / September 11, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the HC Wainwright & Co. Global Investment Conference on Tuesday, September 15 at 3:00 PM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting and available for one-on-one investor meetings.

Institutional and other qualified investors may request one-on-one meetings via HC Wainwright & Co. if they have an existing relationship, or by contacting Apollo 's investor relations, Matt Kreps of Darrow Associates, at [email protected].

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.


Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
[email protected]

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
[email protected]

SOURCE: Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc.
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: